CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
no interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06219031
NCT06219031N/ACompleted

A Study of the Tumor Microenvironment Affecting the Efficacy of Immunotherapy for Esophageal Cancer

Renmin Hospital of Wuhan University·observational·Posted Jan 23, 2024·Updated Jan 26, 2024

In Brief

An observational study evaluating no intervention for Esophageal Cancer. Completed, enrolled 22 participants across 1 site.

Detailed Summary

This study is a retrospective study of clinical specimens. The study subjects were patients with esophageal cancer who received immunotherapy. Tumor tissue specimens surgically removed from patients before treatment will be collected primarily. In situ immunohistochemistry and multicolor immunofluorescence will be performed. We hypothesize that there are differences in lipid metabolism-related proteins in tumor tissues and immune cells in the preexisting tumor microenvironment in patients with esophageal cancer prior to immunotherapy, and that there is a link between such differences and the efficacy of immunotherapy.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedJan 23, 2024
Enrollment StartDec 1, 2023
Primary CompletionDec 1, 2023
Study CompletionJan 1, 2024
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 2.4 years ago

Interventions

no interventionother

no intervention